Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share - Schedule of anti-dilutive securities (Details)

v3.24.2.u1
Loss Per Share - Schedule of anti-dilutive securities (Details) - shares
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 15,308,343 14,569,242
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 4,103,267 4,743,466
Stock options and stock appreciation rights    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 9,136,058 9,562,621
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 2,069,018 263,155